Health-Related Quality of Life in Chronic Hepatitis C

Overview

Journal GE Port J Gastroenterol

Specialty Gastroenterology

Date 2017 Aug 30

PMID 28848783

Citations 4

Authors

Helder Cardoso

Marco Silva

Affiliations

Soon will be listed here.

Citing Articles

Trends in Hospitalizations of Patients with Hepatitis C Virus in Poland between 2012 and 2022.

Genowska A, Zarebska-Michaluk D, Dobrowolska K, Kanecki K, Gorynski P, Tyszko P J Clin Med. 2024; 13(18).

PMID: 39337105 PMC: 11433470. DOI: 10.3390/jcm13185618.

Assessment of hepatitis-related knowledge, attitudes, and practices on quality of life with the moderating role of internalized stigma among hepatitis B-positive patients in Pakistan.

Ahmed S, Mendez R, Naveed S, Akhter S, Mushtaque I, Malik M Health Psychol Behav Med. 2023; 11(1):2192782.

PMID: 37008419 PMC: 10064821. DOI: 10.1080/21642850.2023.2192782.

DEPRESSION, ANXIETY AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION IN VOJVODINA.

Kacavenda-Babovic D, duric P, Babovic R, Fabri M, Ruzic M, Ignjatovic V Acta Clin Croat. 2022; 60(4):579-589.

PMID: 35734493 PMC: 9196232. DOI: 10.20471/acc.2021.60.04.03.

Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.

Han R, Francois C, Toumi M Appl Health Econ Health Policy. 2020; 19(1):29-44.

PMID: 32661846 DOI: 10.1007/s40258-020-00600-w.

References

European Association For The Study Of The Liver . Corrigendum to 'EASL recommendations on treatment of hepatitis C: Final update of the series [J Hepatol 73 (2020) 1170-1218]. J Hepatol. 2022; 78(2):452. DOI: 10.1016/j.jhep.2022.10.006. View

Rei A, Rocha M, Pedroto I . Health-Related Quality of Life in Portuguese Patients with Chronic Hepatitis C. GE Port J Gastroenterol. 2017; 24(2):68-78. PMC: 5553367. DOI: 10.1159/000450875. View

Younossi Z, Stepanova M, Marcellin P, Afdhal N, Kowdley K, Zeuzem S . Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials. Hepatology. 2015; 61(6):1798-808. DOI: 10.1002/hep.27724. View

Cruz Neves A, Dickens C, Xavier M . [Comorbidity between hepatitis C and depression. Epidemiological and etiopathogenic aspects]. Acta Med Port. 2006; 19(1):21-8. View

Younossi Z, Stepanova M, Sulkowski M, Foster G, Reau N, Mangia A . Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials. Clin Infect Dis. 2016; 63(8):1042-1048. PMC: 6276885. DOI: 10.1093/cid/ciw496. View

Younossi Z, Kallman J, Kincaid J . The effects of HCV infection and management on health-related quality of life. Hepatology. 2007; 45(3):806-16. DOI: 10.1002/hep.21565. View

Marinho R, Barreira D . Hepatitis C, stigma and cure. World J Gastroenterol. 2013; 19(40):6703-9. PMC: 3812468. DOI: 10.3748/wjg.v19.i40.6703. View

Bonkovsky H, Snow K, Malet P, Back-Madruga C, Fontana R, Sterling R . Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. 2007; 46(3):420-31. PMC: 1995129. DOI: 10.1016/j.jhep.2006.10.009. View

Foster G, Goldin R, Thomas H . Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology. 1998; 27(1):209-12. DOI: 10.1002/hep.510270132. View

10.

Younossi Z, Stepanova M, Nader F, Jacobson I, Gane E, Nelson D . Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens. Hepatology. 2014; 59(6):2161-9. DOI: 10.1002/hep.27161. View

11.

Vietri J, Prajapati G, El Khoury A . The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries. BMC Gastroenterol. 2013; 13:16. PMC: 3551635. DOI: 10.1186/1471-230X-13-16. View

12.

Fialho R, Pereira M, Bucur M, Fisher M, Whale R, Rusted J . Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis. AIDS Care. 2015; . DOI: 10.1080/09540121.2015.1108385. View

13.

Innes H, McDonald S, Dillon J, Allen S, Hayes P, Goldberg D . Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes. Hepatology. 2015; 62(2):355-64. DOI: 10.1002/hep.27766. View

14.

Marcellin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Varastet M . Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study. Liver Int. 2011; 31(4):516-24. DOI: 10.1111/j.1478-3231.2011.02461.x. View

15.

Cardoso H, Vale A, Rodrigues S, Goncalves R, Albuquerque A, Pereira P . High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis. J Hepatol. 2016; 65(5):1070-1071. DOI: 10.1016/j.jhep.2016.07.027. View